DFSVX
Price
$62.16
Change
-$0.03 (-0.05%)
Updated
Jul 31 closing price
Net Assets
19.45B
VSRAX
Price
$30.74
Change
+$0.33 (+1.09%)
Updated
Jul 31 closing price
Net Assets
11.11B
Interact to see
Advertisement

DFSVX vs VSRAX

DFSVX vs VSRAX Comparison Chart in %
View a ticker or compare two or three
VS
DFSVX vs. VSRAX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DFSVX is a StrongBuy and VSRAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
DFSVX has more cash in the bank: 19.5B vs. VSRAX (11.1B). DFSVX pays higher dividends than VSRAX: DFSVX (1.50) vs VSRAX (0.02). DFSVX was incepted earlier than VSRAX: DFSVX (33 years) vs VSRAX (6 years). VSRAX (1.35) is less costly to investors than DFSVX (0.31). VSRAX is a more actively managed with annual turnover of: 79.00 vs. DFSVX (7.00). DFSVX has a lower initial minimum investment than VSRAX: DFSVX (0) vs VSRAX (1000). DFSVX annual gain was more profitable for investors over the last year : 34.39 vs. VSRAX (29.47). VSRAX return over 5 years is better than : 53.77 vs. DFSVX (50.66).
DFSVXVSRAXDFSVX / VSRAX
Total Expense Ratio0.311.3523%
Annual Report Gross Expense Ratio0.311.3523%
Fund Existence33 years6 years-
Gain YTD21.33622.71594%
Front LoadN/AN/A-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets19.5B11.1B176%
Annual Yield % from dividends1.500.026,125%
Returns for 1 year34.3929.47117%
Returns for 3 years50.3756.6189%
Returns for 5 years50.6653.7794%
Returns for 10 years107.71N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HSVRX54.680.40
+0.74%
Harbor Small Cap Value Admin
DESSX29.040.10
+0.35%
DWS Enhanced Core Equity S
AGIRX22.310.05
+0.22%
Alger Mid Cap Growth Institutional R
IAXSX9.86-0.03
-0.30%
VY® T. Rowe Price Divers Mid Cap Gr S
THISX89.95-1.09
-1.20%
T. Rowe Price Health Sciences I